Navigation Links
New White Paper from Tuberous Sclerosis Alliance Assesses Visual Field Risks of Vigabatrin

SILVER SPRING, Md., Dec. 6, 2013 /PRNewswire-USNewswire/ -- A new white paper from the Tuberous Sclerosis Alliance (TS Alliance), entitled "Vigabatrin-Associated Visual Field Loss (VAVFL): What You Need to Know," was released today at the American Epilepsy Society annual meeting in Washington, DC.  The white paper was written by Darcy A. Krueger, MD, PhD, Associate Professor, Clinical Pediatrics and Neurology, Tuberous Sclerosis Clinic, Cincinnati Children's Hospital. Vigabatrin is approved in the United States by the Food and Drug Administration to treat infantile spasms and medically refractory complex partial seizures that are common in tuberous sclerosis complex (TSC).


"Infantile spasms occur in approximately one-third of children with TSC," says TS Alliance President and CEO Kari Luther Rosbeck. "Because vigabatrin is the first-line medication recommended in the recently released TSC Clinical Consensus Guidelines to treat these types of seizures, it was important to address the medication's side effects, which Dr. Krueger has done in this new white paper." 

"The purpose of this white paper is to provide an authoritative report about vigabatrin-associated visual field loss (VAVFL) based on published clinical reports and studies," Dr. Krueger explains. "This report was written for patients and their families and will help in making an informed decision about the use of vigabatrin to treat infantile spasms and/or complex partial epilepsy." The white paper summarizes and critically evaluates what is known about the prevalence of VAVFL following vigabatrin exposure and possible ways to manage any potential retinal toxicity as reported in published, peer-reviewed publications.  

TSC is a multi-system genetic disorder that causes tumors to form in vital organs, primarily the brain, heart, eyes, kidneys, lungs and skin. It's also the leading genetic cause of both autism and epilepsy.  Approximately 50,000 people in the United States suffer from the disease, and it has an estimated incidence of 1 in 6,000 live births.  More than 1 million people worldwide have TSC.

Formed in 1974, the TS Alliance is the only U.S.-based non-profit organization dedicated to finding a cure for TSC while improving the lives of those affected.  For more information, visit or call 800-225-6872.  The white paper, supported by an unrestricted educational grant from Lundbeck, is available for download at  The new Clinical Consensus Guidelines are available at

For more information contact:
Jaye D. Isham, Vice President, Communications Strategy
(301) 562-9890,

SOURCE Tuberous Sclerosis Alliance
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer - International White Paper Launched at European Cancer Congress 2013
2. Automation is Revolutionizing White Cell Differential Analysis; New Whitepaper Details How
3. RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care
4. New White Paper Details What Compounding Pharmacies Must Know to Prepare for FDA Inspections
5. Scott & White Hospital - Round Rock first in Central Texas, one of few nationally to perform breakthrough procedure for acid reflux
6. Disinfectant Qualification Questions are Answered for Sterile Drug Manufacturers in New White Paper
7. TeamHealth White Paper Examines Telemedicine Risks, Risk Management Strategies
8. Scott & White to Open Emergency Hospital in Cedar Park
9. Heraeus Expands Its Venus White Line of Whitening Maintenance and Oral Care Products
10. MEI Pharma Announces Retirement Of Chairman Bryan Williams From Board Of Directors And Appointment Of Christine White As Lead Director
11. White Paper Details Five Things to Consider Before Buying Spiral Bevel Gear Drives
Post Your Comments:
(Date:10/12/2015)... Oct. 12, 2015  Millions of smokers worldwide have ... shackles of tobacco. An April 2015 study ... London showed electronic cigarettes to be up to 95 ... than a decade after the technology was first introduced ... --> --> ...
(Date:10/12/2015)... , Oct. 12, 2015 About epilepsy ... to a spectrum of brain disorders manifested by benign ... by factors ranging from brain malformations and tumors to ... underlying cause of the disease is unidentified, as is ... as idiopathic epilepsy. An imbalance between the inhibitory and ...
(Date:10/12/2015)... , October 12, 2015 --> ... report "Spirometer Market by Product (Hand-held, Table-top, Desktop), Technology (Volume ... Application, & Geography - Global Forecast to 2020", published by ... Million by 2020, at a CAGR of 9.8% from 2015 ... 128 F igures spread th rough 187 P ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... October 13, 2015 , ... ... Vereb has been named the organization’s Executive Vice President of Operations, and three ... to key leadership roles in the company. , Debbie Vereb’s appointment to Executive ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... technologies and development solutions for drugs, biologics, consumer health and animal health products, ... Technology, and will lead a new, dedicated global team of drug development and ...
(Date:10/12/2015)... (PRWEB) , ... October 12, 2015 , ... According to an article published ... from adults today versus those of a similar group taken in 1988 has shown that ... a person in 2008 with the same diet as someone in 1971 would be on ...
(Date:10/12/2015)... ... October 12, 2015 , ... The American Society of Clinical ... professional education and clinical training in a health care discipline. , Many ... such as: losing weight, managing pain, or stopping smoking, etc. Frequently, extravagant statements ...
(Date:10/12/2015)... ... October 12, 2015 , ... AcousticSheep LLC, creators of the ... honor of Breast Cancer Awareness Month. During the month of October, for ... SleepPhones® Classic product to a breast cancer patient at the Cleveland Clinic. , ...
Breaking Medicine News(10 mins):